0000899243-18-012415.txt : 20180510 0000899243-18-012415.hdr.sgml : 20180510 20180510180457 ACCESSION NUMBER: 0000899243-18-012415 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180508 FILED AS OF DATE: 20180510 DATE AS OF CHANGE: 20180510 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bodmer Mark CENTRAL INDEX KEY: 0001738885 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38473 FILM NUMBER: 18824361 MAIL ADDRESS: STREET 1: C/O EVELO BIOSCIENCES, INC. STREET 2: 620 MEMORIAL DRIVE, SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Evelo Biosciences, Inc. CENTRAL INDEX KEY: 0001694665 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 465594527 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 620 MEMORIAL DRIVE STREET 2: SUITE 200 WEST CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617 870 8281 MAIL ADDRESS: STREET 1: 620 MEMORIAL DRIVE STREET 2: SUITE 200 WEST CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-05-08 0 0001694665 Evelo Biosciences, Inc. EVLO 0001738885 Bodmer Mark 620 MEMORIAL DRIVE, SUITE 200 CAMBRIDGE MA 02139 0 1 0 0 See Remarks Stock Option 16.00 2018-05-08 4 A 0 55437 0.00 A 2028-05-08 Common Stock 55437 55437 D The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the grant date and vests in equal quarterly installments over a three year period thereafter. Chief Scientific Off. & Pres. of R&D /s/ Jonathan Poole, Attorney-in-Fact for Mark Bodmer 2018-05-10